Silver Book Fact

1 and 6-month mortality rates without treatment for sSAS

Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).

Malaisrie C, McDonald E, Kruse J, et al. Mortality While Waiting for Aortic Valve Replacement. The Annals of Thoracic Surgery. 2014; 98. http://www.annalsthoracicsurgery.org/article/S0003-4975(14)01324-1/pdf

Reference

Title
Mortality While Waiting for Aortic Valve Replacement
Publication
The Annals of Thoracic Surgery
Publication Date
2014
Authors
Malaisrie C, McDonald E, Kruse J, et al
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Connected Facts

Related Facts

  • Survival rates of sSAS patients who do not undergo valve replacement
    Patients with severe symptomatic aortic stenosis (sSAS) who do not undergo valve replacement have survival rates as low as 50% at two years and 20% at 5 years after the…  
  • Aortic valve disease costs
    Aortic valve disease (AVD) (symptomatic and asymptomatic) costs the U.S. $10.2 billion in direct costs each year.  
  • Low detection rates for AS
    Prevalence estimates for AS are likely low. A U.K. population screening found previously undetected HVD in 1 in 2 adults ages 65+.  
  • Mean 5-Year Cumulative Total Medical Costs Per Medically Managed (No AVR) Severe AS Patient
     
  • Hospital Discharges from Heart Valve Disease in 2010*